LGT Capital Partners LTD. Raises Stock Holdings in Agilent Technologies, Inc. (NYSE:A)

LGT Capital Partners LTD. boosted its stake in shares of Agilent Technologies, Inc. (NYSE:AGet Rating) by 9.9% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 867,480 shares of the medical research company’s stock after acquiring an additional 77,990 shares during the quarter. Agilent Technologies makes up approximately 3.3% of LGT Capital Partners LTD.’s holdings, making the stock its 8th biggest holding. LGT Capital Partners LTD. owned about 0.29% of Agilent Technologies worth $114,794,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of A. BlackRock Inc. boosted its stake in shares of Agilent Technologies by 6.8% in the 4th quarter. BlackRock Inc. now owns 29,352,219 shares of the medical research company’s stock valued at $4,686,082,000 after purchasing an additional 1,879,602 shares during the last quarter. State Street Corp boosted its stake in shares of Agilent Technologies by 3.1% in the 4th quarter. State Street Corp now owns 13,370,324 shares of the medical research company’s stock valued at $2,134,572,000 after purchasing an additional 401,106 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of Agilent Technologies by 1.8% in the 4th quarter. Geode Capital Management LLC now owns 5,866,133 shares of the medical research company’s stock valued at $934,437,000 after purchasing an additional 103,871 shares during the last quarter. Pictet Asset Management SA boosted its stake in shares of Agilent Technologies by 3.0% in the 4th quarter. Pictet Asset Management SA now owns 4,752,712 shares of the medical research company’s stock valued at $758,770,000 after purchasing an additional 138,793 shares during the last quarter. Finally, Impax Asset Management Group plc boosted its stake in shares of Agilent Technologies by 13.6% in the 4th quarter. Impax Asset Management Group plc now owns 4,540,510 shares of the medical research company’s stock valued at $724,892,000 after purchasing an additional 544,288 shares during the last quarter.

A number of analysts recently weighed in on A shares. KeyCorp cut their price target on shares of Agilent Technologies from $195.00 to $155.00 and set an “overweight” rating on the stock in a research report on Thursday, June 2nd. Bank of America cut their price target on shares of Agilent Technologies from $179.00 to $160.00 and set a “buy” rating on the stock in a research report on Wednesday, February 23rd. SVB Leerink dropped their target price on shares of Agilent Technologies from $175.00 to $145.00 and set an “outperform” rating on the stock in a report on Wednesday, February 23rd. Stifel Nicolaus dropped their target price on shares of Agilent Technologies from $169.00 to $145.00 and set a “hold” rating on the stock in a report on Wednesday, February 23rd. Finally, Cowen dropped their target price on shares of Agilent Technologies from $187.00 to $178.00 and set an “outperform” rating on the stock in a report on Wednesday, February 23rd. Three investment analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $159.91.

In other news, VP Jacob Thaysen sold 5,879 shares of Agilent Technologies stock in a transaction on Thursday, June 2nd. The stock was sold at an average price of $127.43, for a total transaction of $749,160.97. Following the completion of the sale, the vice president now owns 88,737 shares of the company’s stock, valued at $11,307,755.91. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

A stock opened at $113.80 on Thursday. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.01 and a quick ratio of 1.49. The company has a fifty day moving average price of $121.76 and a two-hundred day moving average price of $134.30. Agilent Technologies, Inc. has a one year low of $112.52 and a one year high of $179.57. The stock has a market cap of $33.99 billion, a price-to-earnings ratio of 27.42, a price-to-earnings-growth ratio of 2.32 and a beta of 1.05.

Agilent Technologies (NYSE:AGet Rating) last released its quarterly earnings data on Tuesday, May 24th. The medical research company reported $1.13 EPS for the quarter, topping analysts’ consensus estimates of $1.12 by $0.01. Agilent Technologies had a net margin of 19.35% and a return on equity of 27.42%. The firm had revenue of $1.61 billion during the quarter, compared to analysts’ expectations of $1.62 billion. During the same period in the previous year, the business posted $0.97 earnings per share. The company’s revenue for the quarter was up 5.4% compared to the same quarter last year. Research analysts anticipate that Agilent Technologies, Inc. will post 4.9 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 27th. Stockholders of record on Tuesday, July 5th will be issued a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.74%. The ex-dividend date is Friday, July 1st. Agilent Technologies’s dividend payout ratio is currently 20.24%.

About Agilent Technologies (Get Rating)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

See Also

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.